Bioventures is an opportunity for trainees (those pursuing PhDs, MDs, residency, post-docs, MBAs, undergraduates etc.) engage in a hands on entrepreneurship experience by turning their life science/biotech/medtech ideas into a refined investor pitch deck. The program combines lecture based learning with weekly pitch practice and feedback sessions.
Bioventures alumni have developed 8 companies in the program and have founded 5 other companies after participation. Prior areas of focus include diagnostics, therapeutics, medical devices, and direct to consumer life science products. Collectively alumni have raised $5M+ and have participated in incubators/accelerators including Y Combinator, Mass Challenge, Station Houston, JLABS, and TMCx.
Prior participants have joined us from Rice, BCM, UTMB, Lamar, UT Health, TAMU, UH, MD Anderson, etc. Trainees must be willing to commit 10+ hours per week from June 3 – August 5 to participate in the program. If you are interested in participating, please fill out our signup form. Contact Manwal Harb (email@example.com) for any questions.
Bioventures 2021 runs Thursday evenings June through August.
May 15: Team Formation Day- Pitch your technology or value as a teammate. The best ideas will be identified by mentors and teams will form around these ideas.
June 3 - August 5: Sessions: Hour 1 will be a guest lecture and hours 2-3 will be team pitches with feedback
August 14: Final Pitch Day
Dr. Jordan Milller is an entrepreneur and Bioengineering professor at Rice University. In 2018, he and Dr. Bagrat Grigoryan cofounded Volumetric, Inc. a company that is working on the next generation
Science and entrepreneurship are more similar than you might think. Learn how your skills in science or entrepreneurship can translate into bioentrepreneurship.
Don't know much about vaccines? Read this to get a better idea about them.
Human ignorance is the real pandemic. Misinformation and distrust has spearheaded the anti-vaccine movement.
In this episode, we interviewed to president and CEO of Hera Biotech, Somer Baburek. Hera Biotech is an early-stage, women’s health company, focused on commercializing the first minimally invasive dia
By understanding the basic principles of COVID-19, including its origin, disease progression and detection we can now move towards understanding vaccine development.
Currently there are several extensive studies being conducted to test whether obesity in humans can be treated with the help of immune cells.
In this episode, we speak with Dr. Elizabeth Jaworski, founder and CEO of ClickSeq Technologies, a next generation sequencing service that is simple and affordable.
Subscribe to our newsletter to be notified when new events become available!